Zenpep Capsule, Delayed Release
Product Images NDC 73562-113

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zenpep (NDC 73562-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aimmune Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Lipase 3,000 USP Units)

This appears to be information about a product called "Zenpep" made by "PORE Pharmaceuticals" and distributed by "Garary". The product seems to involve doses of lipase, protease, and amylase, and comes in delayed-release capsules. The rest of the text is difficult to understand due to formatting and errors.*

FDA Label Image

Principal Display Panel (Lipase 5,000 USP Units)

FDA Label Image

Principal Display Panel (Lipase 10,000 USP Units)

The text contains some medical information related to a medication called "Zenpep". It is a pancreatic enzyme supplement used to improve digestion for people who have cystic fibrosis, chronic pancreatitis, pancreatic cancer, or other conditions that affect the pancreas. The medication comes in the form of delayed-release capsules, each containing a specified amount of lipase, protease, and amylase. The text also includes some vague information such as a company name ("Brersstromacac"), a location ("Germany"), and a unique number ("521288 USA"), but it is not clear what they refer to.*

FDA Label Image

Principal Display Panel (Lipase 15,000 USP Units)

Zenpep is a product of Germany that contains protease, amylase, and lipase enzymes. It is distributed by HeathCore Niron and is available via prescription only. The dosage should be determined based on the amount of lipase units and further information can be found in the package insert. Storage conditions are advised and a NDC code is provided. No further information is available due to the poor quality of the scanned text.*

FDA Label Image

Principal Display Panel (Lipase 20,000 USP Units)

FDA Label Image

Principal Display Panel (Lipase 25,000 USP Units)

This is a medication label for Zenpep, a pancreatic enzyme replacement therapy for patients with cystic fibrosis and other conditions that cause pancreatic insufficiency. Each capsule contains 79,000 USP units of protease, 105,000 USP units of amylase, and 80,000 USP units of lipase. The medication guide is enclosed and should be dispensed to each patient. Dosage and administration instructions are not readable. Storage conditions are recommended. The medication is distributed by a company called "Brdgevater" with a German address.*

FDA Label Image

Principal Display Panel (Lipase 40,000 USP Units)

This is a product description for a medication called "Zenpep". The medication comes in the form of delayed-release capsules and is a combination of pancrelipase, lipase, protease and amylase. It is only available with a prescription and is distributed by "et HeathCre Waron". Each box contains 100 capsules with a medication guide included. The medication is manufactured in Germany. The description includes dosage information and a warning about the medication containing FD8C yellow. The rest of the text is difficult to understand due to possible errors during .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.